JP2024515739A5 - - Google Patents
Info
- Publication number
- JP2024515739A5 JP2024515739A5 JP2023565293A JP2023565293A JP2024515739A5 JP 2024515739 A5 JP2024515739 A5 JP 2024515739A5 JP 2023565293 A JP2023565293 A JP 2023565293A JP 2023565293 A JP2023565293 A JP 2023565293A JP 2024515739 A5 JP2024515739 A5 JP 2024515739A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cancer
- independently
- membered
- alkylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2021-0053352 | 2021-04-23 | ||
| KR20210053352 | 2021-04-23 | ||
| PCT/IB2022/053721 WO2022224180A1 (en) | 2021-04-23 | 2022-04-21 | Compound as adenosine a2a receptor antagonist and pharmaceutical composition comprising same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024515739A JP2024515739A (ja) | 2024-04-10 |
| JP2024515739A5 true JP2024515739A5 (https=) | 2024-12-27 |
| JP7646873B2 JP7646873B2 (ja) | 2025-03-17 |
Family
ID=83722733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023565293A Active JP7646873B2 (ja) | 2021-04-23 | 2022-04-21 | アデノシンＡ２ａ受容体アンタゴニストとしての化合物およびこれを含む薬学的組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240217978A1 (https=) |
| EP (1) | EP4326724A4 (https=) |
| JP (1) | JP7646873B2 (https=) |
| KR (1) | KR102863028B1 (https=) |
| CN (1) | CN117120443A (https=) |
| AU (1) | AU2022262777C1 (https=) |
| BR (1) | BR112023021918A2 (https=) |
| CA (1) | CA3207935A1 (https=) |
| MX (1) | MX2023012338A (https=) |
| TW (1) | TWI838736B (https=) |
| WO (1) | WO2022224180A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023296161A1 (en) * | 2022-06-13 | 2025-01-02 | Alivexis, Inc. | Azacycloalkyl carbonyl cyclic amine compound |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0459702A1 (en) * | 1990-05-29 | 1991-12-04 | Zeneca Limited | Azole Derivatives |
| US5356894A (en) | 1990-05-29 | 1994-10-18 | Rodney Peter W | Morpholinyl substituted [1,2,4]-triazolo[1,5-a]triazine as antagonist |
| CA2148502A1 (en) * | 1993-09-06 | 1995-03-16 | Fumio Suzuki | Antidepressants |
| US6232297B1 (en) * | 1999-02-01 | 2001-05-15 | University Of Virginia Patent Foundation | Methods and compositions for treating inflammatory response |
| US6664252B2 (en) * | 1999-12-02 | 2003-12-16 | Osi Pharmaceuticals, Inc. | 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof |
| CA2459304A1 (en) * | 2001-09-13 | 2003-03-20 | Schering Corporation | Combination of an adenosine a2a receptor antagonist and an antidepressant or anxiolytic |
| IL161573A0 (en) * | 2001-11-30 | 2004-09-27 | Schering Corp | [1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTS |
| JPWO2003068776A1 (ja) * | 2002-02-15 | 2005-06-02 | 協和醗酵工業株式会社 | ［１，２，４］トリアゾロ［１，５−ｃ］ピリミジン誘導体 |
| WO2004092173A2 (en) | 2003-04-09 | 2004-10-28 | Biogen Idec Ma Inc. | A2a adenosine receptor antagonists |
| EP3810610A1 (en) * | 2018-05-18 | 2021-04-28 | Incyte Corporation | Fused pyrimidine derivatives as a2a / a2b inhibitors |
| JP7197206B2 (ja) * | 2018-06-26 | 2022-12-27 | チョーチヤン ビムグリーン ファーマシューティカルズ、リミテッド | Ａ２ａ受容体拮抗薬として用いられるトリアゾロトリアジン誘導体 |
| AU2019383948A1 (en) * | 2018-11-20 | 2021-05-20 | Merck Sharp & Dohme Llc | Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use |
| CN112028891B (zh) * | 2019-07-30 | 2022-07-05 | 厦门宝太生物科技股份有限公司 | 腺苷受体拮抗剂 |
-
2022
- 2022-04-21 MX MX2023012338A patent/MX2023012338A/es unknown
- 2022-04-21 AU AU2022262777A patent/AU2022262777C1/en active Active
- 2022-04-21 TW TW111115277A patent/TWI838736B/zh active
- 2022-04-21 EP EP22791230.0A patent/EP4326724A4/en active Pending
- 2022-04-21 KR KR1020220049770A patent/KR102863028B1/ko active Active
- 2022-04-21 BR BR112023021918A patent/BR112023021918A2/pt unknown
- 2022-04-21 CA CA3207935A patent/CA3207935A1/en active Pending
- 2022-04-21 US US18/287,743 patent/US20240217978A1/en active Pending
- 2022-04-21 WO PCT/IB2022/053721 patent/WO2022224180A1/en not_active Ceased
- 2022-04-21 CN CN202280022844.9A patent/CN117120443A/zh active Pending
- 2022-04-21 JP JP2023565293A patent/JP7646873B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020517616A5 (https=) | ||
| JP2020537657A5 (https=) | ||
| JP2024534804A5 (https=) | ||
| JP2020528889A5 (https=) | ||
| IL268030B2 (en) | Bicyclics as allosteric shp2 inhibitors | |
| JP2021513967A5 (https=) | ||
| JP2013525458A5 (https=) | ||
| JP2006515858A5 (https=) | ||
| JP2003534325A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| RU2019142795A (ru) | Производное n-(азаарил)циклолактам-1-карбоксамида, метод его получения и его применение | |
| JP2008528447A5 (https=) | ||
| JP2014500870A5 (https=) | ||
| JP2008505117A5 (https=) | ||
| JP2025510074A5 (https=) | ||
| JP2005505618A5 (https=) | ||
| JP2024515739A5 (https=) | ||
| JP2006514960A5 (https=) | ||
| CN114026068A (zh) | Ep2拮抗剂 | |
| JP2004520423A5 (https=) | ||
| JP2005517008A5 (https=) | ||
| JP2010534669A5 (https=) | ||
| JP2012500249A5 (https=) | ||
| TWI833796B (zh) | 磷酸肌醇3激酶(pi3k)抑制劑之結晶形式 | |
| RU2007123615A (ru) | Производные 3-[2-(3-ациламино-2-оксо-2н-пиридин-1-ил)-ацетиламино]-4-оксо-пентановой кислоты и их применение в качестве ингибиторов каспазы |